US stock · US markets · public data

ELV

Elevance Health Inc · Healthcare

Reference price$427.03Updated according to the public source
P/E18.90
P/B2.06
ROE11.13%
DY 12M1.61%
Net margin—
Net debt/equity—
Market capUS$ 92.6 B
Volume (shares)1,248,918
SectorHealthcare
Overview

About ELV

Demonstrações públicas consolidadas + SEC Company Facts

Elevance Health Inc (ELV) is a stock traded in US markets in the Healthcare sector. The consulted sources did not provide revenue, net income or operating cash flow for the latest reported periods.

Available statements: Income statement, Balance sheet, Cash flow. Most recent period in the first statement: 2026.

Distributions

Dividends and distributions · last 12 records

public data
09/22
03/23
06/23
09/23
03/24
06/24
09/24
03/25
06/25
09/25
03/26
06/26
Income in shown records$19.18
DY 12M1.61%
Records shown12
Date / reported periodTypeValue per share/unit
Period ending 2026-06-30Dividendo declarado$1.72
Period ending 2026-03-31Dividendo declarado$1.72
Period ending 2025-09-30Dividendo declarado$1.71
Period ending 2025-06-30Dividendo declarado$1.71
Period ending 2025-03-31Dividendo declarado$1.71
Period ending 2024-09-30Dividendo declarado$1.63

SEC records describe reported fiscal periods, not ex-dividend or payment dates. Only separately reported quarters are shown; missing quarters do not mean zero dividends.

Financials

Income statement, balance sheet and cash flow

Available

Income statement

Account2023202420252026
Revenue$171,340,000,000.00$177,011,000,000.00$199,125,000,000.00—
Operating Income$8,499,000,000.00$7,862,000,000.00$7,199,000,000.00—
Net Income$5,987,000,000.00$5,980,000,000.00$5,662,000,000.00—
EPS Diluted$25.22 / share$25.68 / share$25.21 / share—

Balance sheet

Account2023202420252026
Total Assets$108,928,000,000.00$116,889,000,000.00$121,494,000,000.00—
Total Liabilities$69,523,000,000.00$75,463,000,000.00$77,468,000,000.00—
Total Equity$39,306,000,000.00$41,315,000,000.00$43,882,000,000.00—
Long-term Debt$23,246,000,000.00$29,218,000,000.00$30,797,000,000.00—
Current Debt$1,649,000,000.00$1,649,000,000.00$1,099,000,000.00—
Shares Outstanding237,457,776 shares232,668,735 shares227,351,871 shares220,704,667 shares
Cash & Investments————
Dívida Líquida————

Cash flow

Account2023202420252026
Operating Cash Flow$8,061,000,000.00$5,808,000,000.00$4,290,000,000.00—
Capital Expenditures$1,296,000,000.00$1,256,000,000.00$1,116,000,000.00—
Dividends Paid$1,395,000,000.00$1,508,000,000.00$1,529,000,000.00—
Free Cash Flow$6,765,000,000.00$4,552,000,000.00$3,174,000,000.00—
FAQ

Frequently asked questions

What is the price of ELV?

The reference price available for ELV is $427.03.

What is the P/E of ELV?

The P/E ratio of ELV is 18.90. This compares price with reported earnings per share; a non-positive multiple is not a low positive earnings multiple.

What is the P/B of ELV?

The P/B of ELV is 2.06. This compares price with reported book value per share.

What is the ROE of ELV?

The ROE (Return on Equity) of ELV is 11.13%. This relates the reported net result to shareholders' equity.

What is the dividend yield of ELV?

The dividend yield of ELV is 1.61%. The provider may use annualized dividends; this is not a guaranteed return.

What is the market cap of ELV?

The market capitalization of ELV is US$ 92.6 B.

What sector is ELV in?

ELV operates in the Healthcare sector.

FundamentalRadar · educational information, not investment advice.